PMID- 19138937 OWN - NLM STAT- MEDLINE DCOM- 20090305 LR - 20220321 IS - 1940-6215 (Electronic) IS - 1940-6215 (Linking) VI - 1 IP - 1 DP - 2008 Jun TI - Dietary energy balance modulates signaling through the Akt/mammalian target of rapamycin pathways in multiple epithelial tissues. PG - 65-76 LID - 10.1158/1940-6207.CAPR-08-0022 [doi] AB - The prevalence of obesity, an established risk factor for several types of cancer, has increased steadily over the past several decades in the United States. New targets and strategies for offsetting the effect of obesity on cancer risk are urgently needed. In the present study, we examined the effect of dietary energy balance manipulation on steady-state signaling in multiple epithelial tissues, with a focus on the Akt and mammalian target of rapamycin (mTOR) pathways. For these experiments, male FVB/N and C57BL/6 and female ICR mice were maintained on a control (10 kcal% fat) diet, a diet-induced obesity (DIO; 60 kcal% fat) regimen, or a 30% calorie restriction (CR) regimen for 15 to 17 weeks. Relative to the control group, the DIO regimen increased, whereas CR decreased, circulating insulin-like growth factor-I (IGF-I) as has previously been reported. Western blot analyses showed that the DIO regimen enhanced, whereas CR inhibited, activation of Akt and mTOR, regardless of epithelial tissue or genetic background. In contrast, activation of AMP-activated protein kinase was modulated by dietary energy balance manipulation in the liver but not in the epidermis or dorsolateral prostate. Western blot analyses of epidermal extracts taken from ICR mice also revealed reduced activation of both the IGF-I receptor and epidermal growth factor receptor in CR mice, compared with control mice or mice maintained on the DIO regimen. Taken together, these novel findings suggest that dietary energy balance modulates signaling through cell-surface receptors (i.e., IGF-I receptor and epidermal growth factor receptor), affecting activation of multiple downstream pathways including Akt and mTOR, thus providing important dietary and pharmacologic targets for disrupting the obesity-cancer link. FAU - Moore, Tricia AU - Moore T AD - Science Park-Research Division, The University of Texas M. D. Anderson Cancer Center, Smithville, TX 78957, USA. FAU - Beltran, Linda AU - Beltran L FAU - Carbajal, Steve AU - Carbajal S FAU - Strom, Sara AU - Strom S FAU - Traag, Jeanine AU - Traag J FAU - Hursting, Stephen D AU - Hursting SD FAU - DiGiovanni, John AU - DiGiovanni J LA - eng GR - CA107588/CA/NCI NIH HHS/United States GR - CA16672/CA/NCI NIH HHS/United States GR - CA37111/CA/NCI NIH HHS/United States GR - ES007247/ES/NIEHS NIH HHS/United States GR - ES007784/ES/NIEHS NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural DEP - 20080331 PL - United States TA - Cancer Prev Res (Phila) JT - Cancer prevention research (Philadelphia, Pa.) JID - 101479409 RN - 67763-96-6 (Insulin-Like Growth Factor I) RN - EC 2.7.- (Protein Kinases) RN - EC 2.7.1.1 (mTOR protein, mouse) RN - EC 2.7.11.1 (Oncogene Protein v-akt) RN - EC 2.7.11.1 (TOR Serine-Threonine Kinases) SB - IM EIN - Cancer Prev Res (Phila Pa). 2009 Nov;2(11):999 MH - Animals MH - Body Fat Distribution MH - Body Weight MH - *Diet MH - Eating/physiology MH - Energy Metabolism/*physiology MH - Epithelium/*metabolism MH - Female MH - Homeostasis/physiology MH - Insulin-Like Growth Factor I/analysis/metabolism MH - Male MH - Mice MH - Mice, Inbred C57BL MH - Mice, Inbred ICR MH - Oncogene Protein v-akt/metabolism/*physiology MH - Protein Kinases/metabolism/*physiology MH - Signal Transduction/physiology MH - TOR Serine-Threonine Kinases EDAT- 2009/01/14 09:00 MHDA- 2009/03/06 09:00 CRDT- 2009/01/14 09:00 PHST- 2009/01/14 09:00 [entrez] PHST- 2009/01/14 09:00 [pubmed] PHST- 2009/03/06 09:00 [medline] AID - 1940-6207.CAPR-08-0022 [pii] AID - 10.1158/1940-6207.CAPR-08-0022 [doi] PST - ppublish SO - Cancer Prev Res (Phila). 2008 Jun;1(1):65-76. doi: 10.1158/1940-6207.CAPR-08-0022. Epub 2008 Mar 31.